Television viewers are used to being bombarded with savvy ads from Hims & Hers Health for erectile dysfunction or hair-loss medications. Hims & Hers announced it is adding GLP-1 injections to its weight loss offering, sending its stock up more than 30% on Monday.
David Wainer is a columnist for The Wall Street Journal and Yahoo Finance. He specializes in writing about the intersection of finance, healthcare, and biotechnology, providing insights into investment trends and market analysis. His work has also been featured in JD Supra.